Table 3.
Descriptive statistics of levels of spontaneous and chewing pain during 0.019*0.025 NiTi and 0.019*0.025 SS archwires in the three groups along with p-values of significance testing.
| 0.019*0.025 NiTi | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time | Group | N | Spontaneous pain | Chewing pain | ||||||
| Mean (SD) | P-value* | Pairwise comparisons § | Mean (SD) | P-value* | Pairwise comparisons§ | |||||
| Pair | P-value† | Pair | P-value† | |||||||
| h0 | Laser | 17 | 0.6 (0.6) | 0.499 | 0.8 (0.8) | 0.333 | ||||
| Drug | 17 | 0.8 (0.9) | 0.8 (1) | |||||||
| Control | 17 | 1.2 (1.4) | 1.5 (1.4) | |||||||
| 1 h | Laser | 17 | 0.9 (1) | 0.138 | 1.4 (0.9) | 0.183 | ||||
| Drug | 17 | 0.9 (1.1) | 1.4 (1.7) | |||||||
| Control | 17 | 1.8 (1.5) | 2.2 (1.8) | |||||||
| 24 h | Laser | 17 | 1.6 (1.5) | 0.007 | Laser vs. Drug | 0.049 | 2.5 (1.9) | 0.045 | Laser vs. Drug | 0.062 |
| Drug | 17 | 0.7 (1.2) | Laser vs. Control | 0.005 | 1.4 (1.8) | Laser vs. Control | 0.012 | |||
| Control | 17 | 2.8 (2.2) | Drug vs. Control | 0.131 | 3.1 (2.2) | Drug vs. Control | 0.586 | |||
| 48 h | Laser | 17 | 1.5 (1.5) | 0.019 | Laser vs. Drug | 0.053 | 2.1 (2) | 0.042 | Laser vs. Drug | 0.073 |
| Drug | 17 | 0.5 (1) | Laser vs. Control | 0.015 | 0.9 (1.4) | Laser vs. Control | 0.015 | |||
| Control | 17 | 2.5 (2.5) | Drug vs. Control | 0.322 | 2.7 (2.3) | Drug vs. Control | 0.496 | |||
| 1 week | Laser | 17 | 0.2 (0.5) | 0.056 | 0.5 (0.8) | 0.192 | ||||
| Drug | 17 | 0.2 (0.6) | 0.4 (0.7) | |||||||
| Control | 17 | 1.1 (1.4) | 1.2 (1.5) | |||||||
| Next visit | Laser | 17 | 0.1 (0.2) | 0.128 | 0.1 (0.5) | 0.307 | ||||
| Drug | 17 | 0.1 (0.3) | 0.2 (0.5) | |||||||
| Control | 17 | 0.5 (0.9) | 0.5 (0.9) | |||||||
| 0.019*0.025 SS | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time | Group | N | Spontaneous pain | Chewing pain | ||||||
| Mean (SD) | P-value* | Pairwise comparisons § | Mean (SD) | P-value* | Pairwise comparisons§ | |||||
| Pair | P-value† | Pair | P-value† | |||||||
| h0 | Laser | 17 | 0.4 (0.6) | 0.055 | 0.5 (0.8) | 0.390 | ||||
| Drug | 17 | 0.7 (0.7) | 1.1 (1.1) | |||||||
| Control | 17 | 1.2 (1.2) | 1.4 (1.2) | |||||||
| 1 h | Laser | 17 | 0.7 (0.8) | 0.260 | 0.8 (0.7) | 0.090 | ||||
| Drug | 17 | 0.9 (0.9) | 1.5 (1.3) | |||||||
| Control | 17 | 1.7 (1.2) | 2.2 (1.3) | |||||||
| 24 h | Laser | 17 | 0.5 (0.7) | 0.007 | Laser vs. Drug | 0.218 | 0.9 (1) | 0.015 | Laser vs. Drug | 0.182 |
| Drug | 17 | 1.1 (1.1) | Laser vs. Control | 0.003 | 1.6 (1.3) | Laser vs. Control | 0.006 | |||
| Control | 17 | 2.4 (2.3) | Drug vs. Control | 0.053 | 2.9 (2.4) | Drug vs. Control | 0.099 | |||
| 48 h | Laser | 17 | 0.5 (0.9) | 0.021 | Laser vs. Drug | 0.865 | 0.8 (0.8) | 0.042 | Laser vs. Drug | 0.786 |
| Drug | 17 | 0.5 (0.9) | Laser vs. Control | 0.014 | 0.9 (1.3) | Laser vs. Control | 0.007 | |||
| Control | 17 | 1.9 (1.9) | Drug vs. Control | 0.034 | 2.3 (2.1) | Drug vs. Control | 0.231 | |||
| 1 week | Laser | 17 | 0.4 (0.8) | 0.330 | 0.2 (0.6) | 0.420 | ||||
| Drug | 17 | 0.2 (0.7) | 0.5 (0.9) | |||||||
| Control | 17 | 1 (1.4) | 1.3 (1.6) | |||||||
| Next visit | Laser | 17 | 0.0 (0) | 0.190 | 0.1 (0.2) | 0.060 | ||||
| Drug | 17 | 0.1 (0.2) | 0.1 (0.2) | |||||||
| Control | 17 | 0.7 (1.7) | 0.8 (1.8) | |||||||
* Kruskal-Wallis test was applied; †: Mann-Whitney U test was used for pairwise comparisons; §: pairwise comparisons were applied when a significant difference was found between the groups in general; level of significance was set at 0.05 and Bonferroni’s correction was applied for post-hoc tests (i.e., adjusted α = 0.016); N: number of patients; h0: immediately after activation.